Terug
44
Ook genoteerd als
FPAFF
OTC
Dagbereik
€ 3,63
€ 3,64
52-Weeksbereik
€ 2,67
€ 4,44
Volume
515
50D / 200D Gem.
€ 3,99
/
€ 4,02
Vorige Slotkoers
€ 3,62
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 5,2 | 10,5 |
| P/B | 0,8 | 1,2 |
| ROE % | 15,8 | 12,3 |
| Net Margin % | 6,0 | 5,3 |
| Rev Growth 5Y % | 9,0 | 5,5 |
| D/E | 3,2 | 0,6 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,90
€ 0,87 – € 0,93
|
12 B | 1 |
| FY2026 |
€ 0,85
€ 0,82 – € 0,88
|
11 B | 1 |
Belangrijkste Punten
Revenue grew 8,98% annually over 5 years — modest growth
Earnings grew 19,77% over the past year
ROE of 15,77% — decent returns on equity
Debt/Equity of 3,21 — high leverage
Generating 388,10M in free cash flow
P/E of 5,15 — trading at a low valuation
Groei
Revenue Growth (5Y)
8,98%
Revenue (1Y)-4,31%
Earnings (1Y)19,77%
FCF Growth (3Y)-41,21%
Kwaliteit
Return on Equity
15,77%
ROIC9,97%
Net Margin5,97%
Op. Margin21,87%
Veiligheid
Debt / Equity
3,21
Current Ratio1,35
Interest Coverage3,62
Waardering
P/E Ratio
5,15
P/B Ratio0,79
EV/EBITDA5,84
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,31% | Revenue Growth (3Y) | -1,21% |
| Earnings Growth (1Y) | 19,77% | Earnings Growth (3Y) | 23,81% |
| Revenue Growth (5Y) | 8,98% | Earnings Growth (5Y) | 45,89% |
| Profitability | |||
| Revenue (TTM) | 10,06B | Net Income (TTM) | 600,30M |
| ROE | 15,77% | ROA | 2,09% |
| Gross Margin | 36,34% | Operating Margin | 21,87% |
| Net Margin | 5,97% | Free Cash Flow (TTM) | 388,10M |
| ROIC | 9,97% | FCF Growth (3Y) | -41,21% |
| Safety | |||
| Debt / Equity | 3,21 | Current Ratio | 1,35 |
| Interest Coverage | 3,62 | Dividend Yield | 0,06% |
| Valuation | |||
| P/E Ratio | 5,15 | P/B Ratio | 0,79 |
| P/S Ratio | 0,31 | PEG Ratio | 0,24 |
| EV/EBITDA | 5,84 | Dividend Yield | 0,06% |
| Market Cap | 3,09B | Enterprise Value | 12,85B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 10,06B | 10,51B | 10,30B | 9,10B | 7,13B |
| Net Income | 600,30M | 501,20M | 391,60M | 244,50M | 132,50M |
| EPS (Diluted) | 0,70 | 0,60 | 0,46 | 0,28 | 0,15 |
| Gross Profit | 3,65B | 3,37B | 3,06B | 2,83B | 2,31B |
| Operating Income | 2,20B | 2,06B | 1,77B | 1,37B | 1,07B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 28,68B | 27,36B | 25,49B | 26,57B | 26,94B |
| Total Liabilities | 16,75B | 15,79B | 15,13B | 15,95B | 16,32B |
| Shareholders' Equity | 3,93B | 3,69B | 3,30B | 3,30B | 3,14B |
| Total Debt | 12,62B | 11,71B | 11,22B | 11,13B | 10,71B |
| Cash & Equivalents | 2,86B | 2,35B | 2,09B | 2,25B | 1,35B |
| Current Assets | 6,74B | 6,06B | 5,18B | 5,81B | 5,98B |
| Current Liabilities | 4,99B | 4,59B | 4,11B | 4,62B | 4,83B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#200 of 670
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026